ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974

Pancreatic Lesions Related To Corn Oil Status Reports Made

March 25, 1983

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009